Imipramine is effective in preventing relapse in electroconvulsive therapy-responsive depressed inpatients with prior pharmacotherapy treatment failure: A randomized, placebo-controlled trial

Journal of Clinical Psychiatry

Volumn 67, Issue 2, 2006, Pages 263-268

  Van Den Broek, Walter W ^a,c   Birkenhäger, Tom K ^a   Mulder, Paul G H ^a   Bruijn, Jan A ^a   Moleman, Peter ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Moleman Psychopharmacology   (Netherlands)

^c NONE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; CLOMIPRAMINE; FLUVOXAMINE; IMIPRAMINE; LITHIUM; MONOAMINE OXIDASE INHIBITOR; NORTRIPTYLINE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ELECTROCONVULSIVE THERAPY; FEMALE; HAMILTON SCALE; HAZARD ASSESSMENT; HUMAN; INCIDENCE; MAJOR DEPRESSION; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RECURRENT DISEASE; SURVIVAL; TREATMENT FAILURE;

EID: 33644819033     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v67n0213     Document Type: Article

References (15)

1. Sackeim HA, Prudic J, Devanand DP, et al. The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J Clin Psychopharmacol 1990;10:96-104
2. Seager CP, Bird RL. Imipramine with electrical treatment in depression: a controlled trial. J Ment Sci 1962;108:704-707
3. Imlah N, Ryan E, Harrington J. The influence of antidepressant drugs on the response to electroconvulsive therapy and on subsequent relapse rates. Neuropsychopharmacology 1965;4:438-442
4. Kay DW, Fahy T, Garside RF. A seven-month double-blind trial of amitriptyline and diazepam in ECT-treated depressed patients. Br J Psychiatry 1970;117:667-671
5. Sackeim HA, Haskett RF, Mulsant BH, et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. JAMA 2001;285:1299-1307
6. Lauritzen L, Odgaard K, Clemmesen L, et al. Relapse prevention by means of paroxetine in ECT-treated patients with major depression: a comparison with imipramine and placebo in medium-term continuation therapy. Acta Psychiatr Scand 1996;94:241-251
7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
8. van den Broek WW, Birkenhäger TK, Mulder PGH, et al. A double-blind randomized study comparing imipramine with fluvoxamine in depressed inpatients. Psychopharmacology (Berl) 2004;175:481-486
9. Birkenhäger TK, van den Broek WW, Mulder PG, et al. Comparison of two-phase treatment with imipramine or fluvoxamine, both followed by lithium addition, in inpatients with major depressive disorder. Am J Psychiatry 2004;161:2060-2065
10. Birkenhäger TK, van den Broek WW, Mulder PG, et al. Efficacy and tolerability of tranylcypromine versus phenelzine: a double-blind study in antidepressant-refractory depressed inpatients. J Clin Psychiatry 2004;65: 1505-1510
11. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
12. Spitzer RL, Endicott J. Schedule for Affective Disorders and Schizophrenia (SADS), Third Edition. New York, NY: Biometric Research, New York State Psychiatric Institute; 1978
13. van den Broek WW, de Lely A, Mulder PGH, et al. Effect of antidepressant medication resistance on short-term response to electroconvulsive therapy. J Clin Psychopharmacol 2004;24:400-403
14. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Dept Health, Education, and Welfare publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976:218-222
15. Mulder RT, Joyce PR, Frampton C. Relationships among measures of treatment outcome in depressed patients. J Affect Disord 2003;76: 127-135